Skip to content

CytomX Therapeutics, Inc.

CTMX· NasdaqCore metricsCIK 1501989

Pharmaceutical preparations552 peers

Last sale
Nov 12, 2026 · -4.92%
Market cap
$442.55M
218M shares
Filings
801
$1.69M
Q3 2026−44.8% FY25 yoy
-$20.00M
Q3 2026N/M FY25 yoy
-$23.50M
Q3 2026N/M FY25 yoy
-$27.56M
Q3 2026derivedN/M FY25 yoy
-$0.09
Q3 2026N/M FY25 yoy
$33.96M
Q3 2026−66.7% FY25 yoy
$442.55M
—
31.5×
1.6×
-11.52%
—

Twelve months to Sep 30, 2026 · derived

Price

$2.0350.67%$2.09past year
Nov 12, 2026 · IEX last sale
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Revenue

$76.20MFY 2025
$138.10M0FY 2014FY 2019FY 2025
PeriodEndedValueKindSource trail
FY 20252025-12-31$76,201,000reported
FY 20242024-12-31$138,103,000reported
FY 20232023-12-31$101,214,000reported
FY 20222022-12-31$53,163,000reported
FY 20212021-12-31$37,312,000 revisedreported
FY 20202020-12-31$68,427,000 revisedreported
FY 20192019-12-31$26,902,000 revisedreported
FY 20182018-12-31$59,502,000reported
FY 20172017-12-31$71,623,000reported
FY 20162016-12-31$12,845,000 revisedreported
FY 20152015-12-31$7,712,000reported
FY 20142014-12-31$5,077,000reported

Pharmaceutical preparations

CytomX Therapeutics, Inc. is the 111th largest of the 553 covered companies the SEC files under this code, by revenue. SIC 2834

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

CytomX Therapeutics, Inc. · CIK 1501989 · Engraved from SEC EDGAR